Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Phase 2
100
about 1.7 years
18+
2 sites in VA
About this study
Researchers are testing whether early screening for heart complications and treatment for iron overload can prevent heart problems and reduce hospitalizations in people with sickle cell disease. The trial will involve using medications like deferasirox, deferiprone, or deferoxamine, along with tests such as echocardiography and electrocardiograms (ECG).
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Deferasirox
- 2.Take Deferiprone
- 3.Take Deferoxamine
- +2 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
deferasirox, deferiprone, deferoxamine
oral (Oral Tablet)
Primary: Incidence of Hospitalization for Sickle Cell Disease Related Complications, Length of Stay for SCD-Related Complications
diagnostic